Mark Stenhouse Prometheus Biosciences, Inc. (RXDX) insider trading activity

RXDX Quotes by TradingView

Mark Stenhouse is Chief Operating Officer of Prometheus Biosciences, Inc.. Currently has a direct ownership of 0 shares of RXDX, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 12,754 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Mark Stenhouse Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Sale (or disposition) back to the issuer
-
12,754 Reduced 100.0%
0 Common Stock
Jun 01 2023
SELL
Other acquisition or disposition
-
14,000 Reduced 52.42%
12,708 Common Stock
Dec 09 2022
BUY
Grant, award, or other acquisition
-
9,811 Added 27.06%
26,442 Common Stock
Mar 16 2021
BUY
Open market or private purchase
$266,000 $19.0 p/Share
14,000 Added 50.0%
14,000 Common Stock

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
MS

Mark Stenhouse

Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on RXDX

Follow Prometheus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXDX shares.

Notify only if

Insider Trading

Get notified when an Prometheus Biosciences, Inc. insider buys or sells RXDX shares.

Notify only if

News

Receive news related to Prometheus Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXDX